These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 26920802

  • 1. Design and synthesis of sarolaner, a novel, once-a-month, oral isoxazoline for the control of fleas and ticks on dogs.
    Curtis MP, Vaillancourt V, Goodwin RM, Chubb NA, Howson W, McTier TL, Pullins A, Zinser EW, Meeus PF, Woods DJ, Hedges L, Stuk T, Price JE, Koch JD, Menon SR.
    Bioorg Med Chem Lett; 2016 Apr 01; 26(7):1831-5. PubMed ID: 26920802
    [Abstract] [Full Text] [Related]

  • 2. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs.
    Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, Lahm GP, Long JK, Xu M, Wagerle T, Jones GS, Dietrich RF, Cordova D, Schroeder ME, Rhoades DF, Benner EA, Confalone PN.
    Vet Parasitol; 2014 Apr 02; 201(3-4):179-89. PubMed ID: 24631502
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
    Becskei C, De Bock F, Illambas J, Mahabir SP, Farkas R, Six RH.
    Vet Parasitol; 2016 May 30; 222():49-55. PubMed ID: 26994516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States.
    Six RH, Everett WR, Young DR, Carter L, Mahabir SP, Honsberger NA, Myers MR, Holzmer S, Chapin S, Rugg JJ.
    Vet Parasitol; 2016 May 30; 222():28-32. PubMed ID: 26935819
    [Abstract] [Full Text] [Related]

  • 10. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats.
    Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, Dryden MW, World Association for the Advancement of Veterinary Parasitology.
    Vet Parasitol; 2013 May 01; 194(1):84-97. PubMed ID: 23741753
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
    Geurden T, Becskei C, Grace S, Strube C, Doherty P, Liebenberg J, Mahabir SP, Slootmans N, Lloyd A, Six RH.
    Vet Parasitol; 2016 May 30; 222():33-6. PubMed ID: 27068640
    [Abstract] [Full Text] [Related]

  • 19. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
    Rohdich N, Roepke RK, Zschiesche E.
    Parasit Vectors; 2014 Mar 04; 7():83. PubMed ID: 24593931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.